Posts Tagged ‘blood thinner’
Stephan Moll, MD writes… Another ‘blood thinner’ medication is now under consideration by the FDA for the treatment of DVT and PE.
On Dec 19th the FDA accepted the application by Bristol-Myers Squibb (BMS) and Pfizer for review of Eliquis (apixaban) for the treatment of DVT and PE and for the reduction in the risk of recurrent DVT and PE. The goal date for a decision by the FDA is August 25, 2014. The press release about this submission from BMS is here. Read the rest of this entry »
Beth Waldron, Clot Connect Program Director and Stephan Moll, MD, Clot Connect Medical Director write….
Patients who have ended their recommended course of prescription anticoagulation treatment are understandably concerned about a clot recurrence and will ask “is there anything I can do to prevent a future clot?” Some have heard from friends or the internet that a particular herb, vitamin, or food will aid in the prevention of DVT and PE.
Since more than half of adults in the United States take a dietary supplement of some kind, it may be helpful to examine the science behind some of the most common natural supplements and foods said to prevent blood clots. Read the rest of this entry »
“I am on warfarin (Coumadin®). Can I donate blood?” No. A person on a blood thinner (anticoagulant), like warfarin, will not be accepted as a blood donor Read the rest of this entry »
At times, individuals who are on blood thinners are considering getting a tattoo. I am not aware of any medical publication assessing the amount of bleeding that were to occur if a patient got a tattoo while on warfarin or other blood thinners. Read the rest of this entry »
The new oral “blood thinner” Pradaxa® (=Dabigatran) was approved by the FDA on October 20th, 2010 (ref 1 and 2). This is huge news! This is the first oral blood thinner alternative to warfarin (=Coumadin®, Jantoven®). At this point, Pradaxa® is only FDA approved for use in patients with irregular heart beat (= atrial fibrillation = a. fib). It is not approved yet for patients with DVT and PE. Read the rest of this entry »